BNH Investment

Private Equity Seoul, South Korea

Overview

BNH Investment is a South Korea-based investment firm specializing in private equity, venture capital, and bio sectors. The firm has invested in over 110 companies, achieving successful investment results through IPOs or M&A. Their portfolio includes companies in the healthcare, biotechnology, and pharmaceutical industries, among others. BNH Investment focuses on early-stage to late-stage investments, including pre-IPO and buyout opportunities. They primarily operate within South Korea, targeting sectors such as healthcare, biotechnology, and pharmaceuticals. The firm has a track record of successful investments, contributing to the growth and development of various companies in the bio and healthcare sectors. Their investment philosophy emphasizes strategic partnerships and value creation through active involvement in portfolio companies. BNH Investment continues to seek opportunities to invest in innovative companies within the bio and healthcare industries, aiming to drive growth and deliver value to stakeholders. Their investment approach is characterized by a hands-on strategy, providing not only capital but also strategic guidance to portfolio companies. This approach has led to successful exits through IPOs and M&A transactions, demonstrating their ability to identify and nurture high-potential companies. BNH Investment's team comprises professionals with expertise in various sectors, enabling them to assess and support a diverse range of investment opportunities. Their commitment to excellence and value creation has established them as a reputable player in the South Korean investment landscape. BNH Investment's focus on the bio and healthcare sectors aligns with the growing demand for innovative solutions in these industries. By investing in companies that address critical health challenges, they contribute to advancements in medical research, patient care, and overall public health. Their strategic investments aim to foster innovation and improve healthcare outcomes, reflecting their dedication to making a positive impact in the sector. In summary, BNH Investment is a dynamic investment firm with a strong presence in the South Korean market. Their expertise in private equity, venture capital, and bio sectors, combined with a strategic investment approach, positions them as a key contributor to the growth and success of companies in the bio and healthcare industries. Their ongoing commitment to innovation and value creation continues to drive their success and influence in the investment community.

Investment Focus

  • Innovative business models
  • Strong management teams
  • Scalable operations
  • Clear exit strategies
  • Alignment with bio and healthcare sectors

Portfolio Companies

Kolmar BNH Co., Ltd.BnH Research Co., Ltd.

Reach BNH Investment directly

Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.

Unlock full contacts →

Frequently asked questions about BNH Investment

What sectors does BNH Investment invest in?

BNH Investment invests in Healthcare, Digital Health, Pharmaceuticals, Medical Devices, Diagnostics and Biotechnology, and is based in Seoul, South Korea. BNH Investment is listed as a private equity in the ConnectSafely investor database.

What stage does BNH Investment invest at?

BNH Investment backs companies at Early Stage, Growth, Late Stage, Pre-IPO and Buyout, writing cheques of 1M - 50M.

Which regions does BNH Investment invest in?

BNH Investment invests across South Korea.

What companies has BNH Investment invested in?

BNH Investment's portfolio includes Kolmar BNH Co., Ltd. and BnH Research Co., Ltd..

How do I contact BNH Investment?

BNH Investment's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.

Last updated · Source: ConnectSafely investor database